ArticleOPEN ACCESS

Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial

Diabetes care
DOI: 10.2337/dc18-1355
38Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Inzucchi, S. E., Wanner, C., Hehnke, U., Zwiener, I., Kaspers, S., Clark, D., … Zinman, B. (2019, April 1). Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial. Diabetes Care. NLM (Medline). https://doi.org/10.2337/dc18-1355

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free